2 DAYS OF HIGH LEVEL CONFERENCES
The Innovative Therapies Days will make the connection between the academic and the industrial worlds: from research, to clinical trials, to industrialisation.
Thursday, October 09th
8:30 : REGISTRATION AND WELCOME COFFEE
9:00 : WELCOME ADRESS
Dr Sylvain Perruche, Med’Inn’Pharma, Besançon, FR
Renaud Gaudillière, PMT director
09:15 : KEYNOTE : Designing scalable Cell Therapy operations from day one
Dr Racha Fayad, KPMG, Zurich, CH
9:45 – 12:00 : SESSION #1 « RESEARCH TO PROOF OF CONCEPT »
Chairpersons : Pr John De Vos, CHU Montpellier and Dr Sylvain Perruche, Med’Inn’Pharma, Besançon, FR
09:45 : Engineering iPSC-derived immune cells
Dr Sjoukje van der Stegen, Chan Zuckerberg BioHub, New-York, USA
10:15 : BREAK – EXHIBITION HALL
11:00 : CeBBOc: a case study in Occitanie in building a regional cell-based biotherapy ecosystem
Pr John De Vos, CHU Montpellier, FRA
11:10 : Extracellular vesicles from iPSC-derived MSCs : An innovative biotherapy for osteoarthritis?
Pr Danièle Noël, IRMB, Montpellier, FRA
11:40 : From spontaneous regeneration to cellular engineering: towards iChondrocyte therapy of articular cartilage
Dr Farida Djouad, IRMB, Montpellier, FRA
12:00-14:00 : LUNCH
12:30-14:30 : EXHIBITION HALL – B2B MEETINGS
14:15-14:45 : SYMPOSIUM CYTIVA : Innovation in CAR-T space: Sefia(tm) platform and non-viral gene transfer solutions
Simon Quenneville and Charles Chesnelong
14:45-17:30 : SESSION #2 « PROOF OF CONCEPT TO CLINIC »
Chairpersons : Dr Jessica Gobbo, CTM Inserm Dijon and Dr Céline Elie-Caille, Institute Femto-ST, FR
14:45 : SGC off-the-shelf innovative immunotherapy to treat cancer : from bench to bedside
Dr George Alzeeb, Brenus Pharma, Lyon, FRA
15:15 : Biotherapies based on extracellular vesicles: from research to innovation
Dr Amanda Silva-Brun, CNRS Université Paris Cité, Paris, FRA
15:45 : Invitrogen™ Vivofectamine™ Delivery Solutions: Advancing genetic medicine innovations with Lipid Nanoparticle (LNP) technologies
Jérôme Cabeau, Thermo Fisher Scientific, FRA
15:50 : BREAK – EXHIBITION HALL
16:30 : Nonclinical development of in vivo CAR-T for autoimmune diseases
Dr Ana Bejanariu, Sanofi, Paris, FRA
17:00 : From Bench to Bedside: Regulatory Strategies and Development Tools to Streamline the Transition from Non-
Clinical to Clinical for Emerging Biotechs
PharmD Damia Benchabane, Alira Health, Paris, FRA
17:45-18:45 : OFFICIAL DELEGATION TOUR
17:45-22:00 : POSTER’S SESSION
18:45-22:00 : NETWORKING COCKTAIL
Opening by representative of the President of Grand Besançon Métropole & representative of the President of the Bourgogne
Franche Comté Region
Friday, October 10th
8:15 : WELCOME COFFEE (KURSAAL)
08:45 : KEYNOTE : The 2025 C> Landscape: Pipeline Dynamics and AI Integration
Gavin Vuddamalay, Mabdesign, Lyon, FR
9:15-12:00 : SESSION #3 : Early-Stage Clinical Trials
Chairpersons : Dr Sylvain Perruche, Med’Inn’Pharma and Dr Jean-Luc Schlick, RD-Biotech, Besançon, FR
09:15 : CAR-T cell in autoimmune diseases: from the laboratory to clinical applications
Pr Dominique Farge-Bancel, CRMR MATHEC, Hôpital St-Louis, AP-HP, Université Paris Cité, Paris, FR
09:45 : Translating MSC Exosome Science into Therapy: Preclinical Evidence and First-in-Human Trial for Psoriasis
Pr Sai Kiang Lim, Paracrine Therapeutics, Singapour
10:15 : BREAK- EXHIBITION HALL
11:00 : ATMP release : from phase I to commercial stage
Dr Hélène Nègre, CELLforCURE by SEQENS, Les Ulis, FRA
11:30 : ATMP regulation in the USA: how does it differ from the EU?
Pr Erika Lietzan, University of Missouri-Columbia, Columbia, USA
12:00-14:00 : LUNCH & Exhibition Hall
12:30-13:50 : B2B MEETINGS
14:00-16:30 : SESSION #4 : SCALE-UP AND GO TO MARKET
Chairpersons : Dr Christophe Ferrand and Dr Marina Deschamps, Right Institute, Besançon, FR
14:00 : Journey of India’s First Indigenous CAR-T Therapy
Dr Rahul Purwar, ImmunoACT, Bombay, India
14:30 : Development of a CAR-T production solution : from idea to market
Guillaume Wallart, Cellquest, Besançon, FRA
15:00 : CAR-T therapy for adult ALL: opportunities and challenges
Dr Claire Roddie, Autolus, London, UK
15:30-15:45 : CONCLUSION & END OF CONGRESS
Dr Marina Deschamps, RIGHT Institute, Besançon, FR
